Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial

NCT02401828 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT02401828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02401828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2015
Completion date
July 31, 2017
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus